McClarren Financial Advisors Inc. Grows Holdings in Sanofi (NASDAQ:SNY)

McClarren Financial Advisors Inc. boosted its holdings in shares of Sanofi (NASDAQ:SNY) by 952.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 600 shares of the company’s stock after purchasing an additional 543 shares during the period. McClarren Financial Advisors Inc.’s holdings in Sanofi were worth $28,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of SNY. Synergy Asset Management LLC purchased a new position in shares of Sanofi during the fourth quarter worth about $25,000. Northwest Investment Counselors LLC acquired a new stake in Sanofi during the 3rd quarter worth approximately $29,000. Concord Wealth Partners grew its stake in shares of Sanofi by 157.8% in the 3rd quarter. Concord Wealth Partners now owns 593 shares of the company’s stock valued at $34,000 after purchasing an additional 363 shares during the last quarter. Fortitude Family Office LLC increased its holdings in shares of Sanofi by 708.6% in the third quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock valued at $43,000 after purchasing an additional 659 shares during the period. Finally, Sunbelt Securities Inc. raised its stake in shares of Sanofi by 72.1% during the third quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock worth $43,000 after purchasing an additional 313 shares during the last quarter. 14.04% of the stock is currently owned by institutional investors and hedge funds.

Sanofi Trading Up 1.2 %

Shares of SNY stock opened at $54.56 on Thursday. The stock has a market cap of $138.46 billion, a P/E ratio of 21.91, a P/E/G ratio of 0.99 and a beta of 0.57. The company has a quick ratio of 0.74, a current ratio of 1.46 and a debt-to-equity ratio of 0.15. Sanofi has a fifty-two week low of $45.22 and a fifty-two week high of $58.97. The business has a fifty day simple moving average of $50.07 and a 200-day simple moving average of $52.41.

Sanofi (NASDAQ:SNY) last posted its earnings results on Thursday, January 30th. The company reported $0.70 earnings per share for the quarter, meeting the consensus estimate of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.58%. On average, analysts forecast that Sanofi will post 4.36 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the stock. Sanford C. Bernstein raised shares of Sanofi to a “strong-buy” rating in a report on Thursday, January 30th. Deutsche Bank Aktiengesellschaft raised Sanofi from a “sell” rating to a “hold” rating in a report on Thursday, January 30th. Finally, StockNews.com cut Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Two research analysts have rated the stock with a hold rating, one has assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Sanofi currently has a consensus rating of “Buy” and an average target price of $60.00.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.